ChainCatcher news, Singapore Web3 platform Galaxis announced a $5 million investment commitment from Bolts Capital to accelerate the expansion of its Decentralized Science (DESCI) program and smart certificate solutions, aimed at leveraging blockchain technology to enhance the capabilities of researchers, institutions, brands, and creators through transparency, authentication, and intellectual property ownership.ChainCatcher previously reported that Singapore Web3 platform Galaxis announced in May 2024 that it had completed $10 million in financing prior to its token issuance. Participants in this round of financing include Chainlink, ENS, Rarestone Capital, Taisu Ventures, and ENS co-founder Nick Johnson, among others.

ChainCatcher news, the encryption research institution Messari recently released an in-depth research report on CESS Network, highlighting the necessity of data value infrastructure for the development of industries such as AI and Web3. Messari systematically analyzes the groundbreaking technological architecture and strategic layout of CESS Network in the field of Web3 data infrastructure in the report.The report points out that the data value infrastructure network built by CESS based on DePIN achieves data valorization, sovereignty return, and privacy protection, addressing three core contradictions in the AI era: the lack of data sovereignty, storage efficiency bottlenecks, and the allocation of computing and storage resources. It drives the integration of Web3 with the real economy and RWA, using compliant data circulation protocols to connect the closed loop of "storage and distribution - rights confirmation and privacy - sharing and circulation," and builds the next-generation infrastructure that supports AI training, DeSci collaboration, and enterprise-level data markets.

ChainCatcher news, the DeSci project Bio Protocol announced plans to create a decentralized BioAgents team capable of using new biotechnological tools by 2025, integrating BIO token economics to complete scientific tasks in longevity research, synthetic biology, and any BioDAO discipline. Bio Protocol will also equip each BioDAO with coordinating agents to allow scientists to focus on scientific research.Such agents will assist in various aspects of community governance, transaction processes, marketing, patient/researcher recruitment, multi-signature management, and more. The BIO token is a key way to incentivize and manage the growth of the BioAgent team. Fees generated by external partners using the BioAgent team will be burned.

ChainCatcher news, according to official sources, ResearchHub has received a $2 million investment from Boost VC.It is reported that BoostVC is deepening its commitment to ResearchHub's mission of accelerating scientific research. This funding will further strengthen ResearchHub's Desci efforts to make research more open, transparent, and collaborative.

ChainCatcher news, according to Theblock, the Sei Foundation has announced the launch of a $65 million venture capital fund named "Sapien Capital --- Open Science Fund I," which focuses on supporting decentralized science (DeSci) startups built on the Sei blockchain.The fund is fully funded by the Sei Foundation and plans to complete capital deployment over the next 3 to 4 years, with investment amounts ranging from $100,000 to $2 million, covering both token and equity forms. DeSci aims to improve the funding model for scientific research, data sharing, and the distribution of scientists' rights through blockchain technology, and has attracted the attention of mainstream institutions such as Binance Labs and a16z.

ChainCatcher news, Pump Science announced that the community voted to approve the community co-construction proposal, launching the ISO concept (Initial Subscription Offering). Token holders can lock in 4% (2% each for RIF/URO) of the future platform's 20 DeSci new projects through token donations for airdrops, with all donated funds used for market making / marketing / listing promotion.Pump Science stated that the RODeo prediction market is now live, and all profits generated will be used to buy back and burn RIF and URO, and it was also mentioned that no new tokens will be created.

ChainCatcher message, Wormhole posted on platform X stating that the BIO protocol will adopt DeSci multi-chain. BIO has natively supported multi-chain using the NTT framework, bringing BIO into the Solana ecosystem and expanding cross-chain access to DeSci liquidity.

ChainCatcher message, Binance co-founder Zhao Changpeng responded to community questions on platform X, "After completing the academy for children, will you consider raising funds to support disease prevention? For example, donating to laboratories?"Zhao Changpeng stated that DeSci can help scientific research laboratories raise funds.

ChainCatcher news, BIO Protocol announced on social media that six new IP tokens are now live for trading, covering projects including: Alzheimer's (CLAW), industrial hemp fiber (HEMPY), ovarian aging (OVARIA), and low-temperature preservation (CRYORAT), among others.This launch is part of a series of significant advancements for BIO Protocol in recent times. The protocol launched its native token $BIO on January 3rd on the Binance and Ethereum mainnets, and plans to introduce $BIO to the Solana and Base networks soon. Additionally, BIO Protocol plans to launch two new BioDAOs, Long COVID Labs (LCL) and Curetopia, this month.BIO Protocol is developing a new decentralized science (DeSci) launchpad aimed at enabling more permissionless BioDAO releases. The protocol also revealed that it will discuss the future development of DeSci in the Solana ecosystem with the Solana Foundation and developers this week.

ChainCatcher news, according to official sources, the DeSci project Big Pharmai (DRUGS) has announced the upcoming launch of a new biological agent framework BADDIE.

ChainCatcher news, according to data from GMGN, the DeSci project VITA has surged past $7, reaching a new all-time high, with a current market cap of $63 million and a 24-hour increase of 36.7%.It is reported that VitaDAO is a community-driven decentralized autonomous organization focused on funding early longevity research, aiming to extend human lifespan and prevent age-related diseases. Its potential lies in democratizing access to scientific innovations by leveraging collective resources and blockchain technology, thereby transforming traditional pharmaceutical models and increasing transparency in drug development.In addition, earlier, the new proposal from VitaDAO "to airdrop 6.9 million BIO to VITA and VitaDAO IPT holders" has opened for voting. The plan is to allocate 6.9 million out of the total 21 million BIO tokens obtained for airdrop to the community.

ChainCatcher message, Ethereum co-founder Vitalik Buterin stated on the Desci podcast that cryptocurrency is an efficient fundraising tool that not only provides more diverse funding sources for DeSci but also significantly enhances the convenience of funding.He has a strong personal interest in longevity research and medical research, and has supported related projects through cryptocurrency, such as donating cryptocurrency to fund India's pandemic response and launching the Balvi pandemic prevention project.Vitalik looks forward to seeing more innovations in the DeSci field, such as:Research contribution distribution mechanisms to fairly confirm the value of scientific work;Interdisciplinary public education funds;Prediction markets to improve decision-making efficiency in research directions.